Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report

Wang L, Zhang X, Huang B, Hou Y, Liu X, Jiao H

Infection and Drug Resistance 2023, 16:2467-2473

Published Date: 26 April 2023